Morgan Stanley Profound Medical Corp. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Profound Medical Corp. stock. As of the latest transaction made, Morgan Stanley holds 3,734 shares of PROF stock, worth $21,619. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,734

Previous 5,234 28.66%

Holding current value

$21,619

Previous $30,000 26.67%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	SELL	$4.04 - $6.86 $6,060 - $10,290	-1,500 Reduced 28.66%	3,734 $22,000
Q1 2025 May 15, 2025	SELL	$5.81 - $7.9 $14,844 - $20,184	-2,555 Reduced 32.8%	5,234 $30,000
Q4 2024 Feb 14, 2025	BUY	$6.98 - $8.96 $22,719 - $29,164	3,255 Added 71.79%	7,789 $58,000
Q2 2024 May 14, 2025	SELL	$7.25 - $9.07 $23,598 - $29,522	-3,255 Reduced 41.79%	4,534 $38,000
Q1 2024 Aug 16, 2024	SELL	$7.3 - $9.46 $14,432 - $18,702	-1,977 Reduced 30.36%	4,534 $38,000
Q1 2024 May 15, 2024	SELL	$7.3 - $9.46 $14,432 - $18,702	-1,977 Reduced 30.36%	4,534 $38,000
Q4 2023 Aug 16, 2024	BUY	$7.85 - $11.18 $15,519 - $22,102	1,977 Added 43.6%	6,511 $55,000
Q4 2023 Feb 13, 2024	SELL	$7.85 - $11.18 $9,600 - $13,673	-1,223 Reduced 15.81%	6,511 $55,000
Q3 2023 Nov 15, 2023	BUY	$7.91 - $13.27 $12,656 - $21,232	1,600 Added 26.08%	7,734 $78,000
Q2 2023 Aug 14, 2023	BUY	$9.27 - $14.88 $9,251 - $14,850	998 Added 19.43%	6,134 $79,000
Q1 2023 May 15, 2023	SELL	$8.85 - $13.27 $12,735 - $19,095	-1,439 Reduced 21.89%	5,136 $47,000
Q4 2022 Feb 14, 2023	SELL	$3.18 - $10.91 $2,057 - $7,058	-647 Reduced 8.96%	6,575 $71,000
Q3 2022 Nov 14, 2022	BUY	$3.99 - $9.3 $1,496 - $3,487	375 Added 5.48%	7,222 $29,000
Q2 2022 Oct 27, 2022	SELL	$6.34 - $9.53 $7,430 - $11,169	-1,172 Reduced 14.62%	6,847 $50,000
Q2 2022 Aug 15, 2022	SELL	$6.34 - $9.53 $7,430 - $11,169	-1,172 Reduced 14.62%	6,847 $50,000
Q1 2022 Oct 27, 2022	BUY	$8.16 - $11.33 $9,563 - $13,278	1,172 Added 17.12%	8,019 $72,000
Q1 2022 May 13, 2022	SELL	$8.16 - $11.33 $6,120 - $8,497	-750 Reduced 8.55%	8,019 $72,000
Q4 2021 Feb 14, 2022	BUY	$10.38 - $15.2 $8,594 - $12,585	828 Added 10.43%	8,769 $99,000
Q3 2021 Nov 15, 2021	BUY	$13.6 - $17.88 $107,997 - $141,985	7,941 New	7,941 $116,000

Others Institutions Holding PROF

# of Institutions

Shares Held

12.6M

Call Options Held

Put Options Held

View Full List

About Profound Medical Corp.

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $121M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

More about PROF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account